
    
      This is a prospective study, observation study in patients receiving allogeneic stem cell
      transplantation in 4 BMT centers in Shanghai. The blood samples (on Day-14, -7, 0 and every 7
      days until D100) and clinical data will be collected. In the final analysis, a panel of
      cytokines and biomarkers analysis of serial blood samples will be carried out and compared
      between patients with no aGVHD and grade II-IV aGVHD.
    
  